Pharmacogenetics of the Human Hydroxycarboxylic Acid Receptor 2 (HCAR2)
Time: 11:30 am
day: Conference Day Two
Details:
- Uncovering GPCR mutations in mouse models that match the human phenotype
- Reviewing how pathway-specific targeting has led to distinct drug properties highlights the ability to fine-tune drug effects
- Determining what is physiologically relevant by assessing the functional context of signaling pathways to ensure that drug effects align with natural biological processes
